Crossmark Global Holdings’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-15,784
| Closed | -$291K | – | 1339 |
|
|
2025
Q2 | $291K | Buy |
15,784
+251
| +2% | +$4.45K | ﹤0.01% | 1113 |
|
|
2025
Q1 | $271K | Sell |
15,533
-210
| -1% | -$3.54K | ﹤0.01% | 1133 |
|
|
2024
Q4 | $273K | Hold |
15,743
| – | – | 0.01% | 1081 |
|
|
2024
Q3 | $293K | Buy |
15,743
+14
| +0.1% | +$236 | 0.01% | 1088 |
|
|
2024
Q2 | $242K | Sell |
15,729
-904
| -5% | -$12.9K | ﹤0.01% | 1153 |
|
|
2024
Q1 | $246K | Sell |
16,633
-157
| -0.9% | -$2.17K | ﹤0.01% | 1188 |
|
|
2023
Q4 | $239K | Sell |
16,790
-412
| -2% | -$5.85K | 0.01% | 1183 |
|
|
2023
Q3 | $245K | Hold |
17,202
| – | – | 0.01% | 1112 |
|
|
2023
Q2 | $223K | Hold |
17,202
| – | – | ﹤0.01% | 1204 |
|
|
2023
Q1 | $198K | Hold |
17,202
| – | – | ﹤0.01% | 1234 |
|
|
2022
Q4 | $213K | Sell |
17,202
-109
| -0.6% | -$1.39K | 0.01% | 1173 |
|
|
2022
Q3 | $227K | Sell |
17,311
-209
| -1% | -$3.09K | 0.01% | 1117 |
|
|
2022
Q2 | $245K | Buy |
17,520
+250
| +1% | +$3.34K | 0.01% | 1135 |
|
|
2022
Q1 | $257K | Buy |
17,270
+610
| +4% | +$8.35K | 0.01% | 1203 |
|
|
2021
Q4 | $226K | Hold |
16,660
| – | – | ﹤0.01% | 1291 |
|
|
2021
Q3 | $245K | Hold |
16,660
| – | – | 0.01% | 1257 |
|
|
2021
Q2 | $303K | Sell |
16,660
-203
| -1% | -$3.61K | 0.01% | 1169 |
|
|
2021
Q1 | $293K | Sell |
16,863
-40
| -0.2% | -$703 | 0.01% | 1179 |
|
|
2020
Q4 | $294K | Hold |
16,903
| – | – | 0.01% | 1106 |
|
|
2020
Q3 | $233K | Buy |
16,903
+30
| +0.2% | +$441 | 0.01% | 1159 |
|
|
2020
Q2 | $243K | Sell |
16,873
-3,130
| -16% | -$41.1K | 0.01% | 1139 |
|
|
2020
Q1 | $218K | Sell |
20,003
-710
| -3% | -$13.1K | 0.01% | 1012 |
|
|
2019
Q4 | $442K | Sell |
20,713
-30
| -0.1% | -$672 | 0.01% | 865 |
|
|
2019
Q3 | $476K | Sell |
20,743
-749
| -3% | -$16K | 0.01% | 804 |
|
|
2019
Q2 | $423K | Sell |
21,492
-94
| -0.4% | -$1.83K | 0.01% | 898 |
|
|
2019
Q1 | $420K | Sell |
21,586
-270
| -1% | -$5.12K | 0.01% | 919 |
|
|
2018
Q4 | $360K | Hold |
21,856
| – | – | 0.01% | 949 |
|
|
2018
Q3 | $505K | Buy |
21,856
+1,499
| +7% | +$34K | 0.01% | 944 |
|
|
2018
Q2 | $442K | Sell |
20,357
-199
| -1% | -$3.89K | 0.01% | 1028 |
|
|
2018
Q1 | $363K | Sell |
20,556
-380
| -2% | -$6.7K | 0.01% | 1133 |
|
|
2017
Q4 | $393K | Buy |
20,936
+7,961
| +61% | +$158K | 0.01% | 1175 |
|
|
2017
Q3 | $285K | Buy |
+12,975
| New | +$293K | 0.01% | 1353 |
|
|
2016
Q3 | $285K | Buy |
+12,975
| New | +$311K | 0.01% | 1353 |
|
Other funds holding SBRA
EGM
N
Crossmark Global Holdings's SBRA Position: Q3 2025 in Review
Crossmark Global Holdings sold out of Sabra Healthcare REIT (SBRA) in Q3 2025, closing a stake of 15,784 shares — an estimated $291K sold.
Crossmark Global Holdings first reported a position in SBRA in Q3 2016 and held it in 33 quarters. The position peaked at $505K in Q3 2018. 424 funds tracked by Wall St. Rank hold SBRA as of Q3 2025.
- Crossmark Global Holdings reported no remaining Sabra Healthcare REIT position as of Q3 2025 after selling out during the quarter.
- Crossmark Global Holdings sold 15,784 Sabra Healthcare REIT shares in Q3 2025, an estimated $291K.
- Crossmark Global Holdings first reported a position in Sabra Healthcare REIT in Q3 2016 and held it in 33 quarters.
- Crossmark Global Holdings's Sabra Healthcare REIT position peaked at $505K in Q3 2018.
- 424 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2025.
Based on Crossmark Global Holdings's 13F filing for Q3 2025, filed 12 Nov 2025.